Chris Kato

Kanagawa, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Therapeutic frontiers in ALS: iPSC-based drug discovery, cell therapy, and gene therapy-Advances through 2026.

Therapeutic frontiers in ALS: iPSC-based drug discovery, cell therapy, and gene therapy-Advances through 2026.

Journal: Regenerative therapy

Published: April 05, 2026

Diagnostic potential of cryptic exon-derived peptides in serum extracellular vesicles for sporadic amyotrophic lateral sclerosis.

Diagnostic potential of cryptic exon-derived peptides in serum extracellular vesicles for sporadic amyotrophic lateral sclerosis.

Journal: Inflammation and regeneration

Published: September 03, 2025

Cerebrospinal fluid extracellular vesicle-derived miR-9-3p in spinal cord injury with neuroprotective implications and biomarker development.

Cerebrospinal fluid extracellular vesicle-derived miR-9-3p in spinal cord injury with neuroprotective implications and biomarker development.

Journal: Communications biology

Published: April 27, 2025

Ropinirole Functions Through a Dopamine Receptor D2-Independent Mechanism to Ameliorate Amyotrophic Lateral Sclerosis Phenotypes in TARDBP-Mutant iPSC-Derived Motor Neurons.

Ropinirole Functions Through a Dopamine Receptor D2-Independent Mechanism to Ameliorate Amyotrophic Lateral Sclerosis Phenotypes in TARDBP-Mutant iPSC-Derived Motor Neurons.

Journal: Journal of neurochemistry

Published: December 19, 2024

Proteomic insights into extracellular vesicles in ALS for therapeutic potential of Ropinirole and biomarker discovery.

Proteomic insights into extracellular vesicles in ALS for therapeutic potential of Ropinirole and biomarker discovery.

Journal: Inflammation and regeneration

Published: April 03, 2024

Spinal cord motor neuron phenotypes and polygenic risk scores in sporadic amyotrophic lateral sclerosis: deciphering the disease pathology and therapeutic potential of ropinirole hydrochloride.

Spinal cord motor neuron phenotypes and polygenic risk scores in sporadic amyotrophic lateral sclerosis: deciphering the disease pathology and therapeutic potential of ropinirole hydrochloride.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: February 25, 2024

Aberrant CHCHD2-associated mitochondriopathy in Kii ALS/PDC astrocytes.

Aberrant CHCHD2-associated mitochondriopathy in Kii ALS/PDC astrocytes.

Journal: Acta neuropathologica

Published: October 13, 2023

Induced pluripotent stem cells-based disease modeling, drug screening, clinical trials, and reverse translational research for amyotrophic lateral sclerosis.

Induced pluripotent stem cells-based disease modeling, drug screening, clinical trials, and reverse translational research for amyotrophic lateral sclerosis.

Journal: Journal of neurochemistry

Published: July 27, 2023

Multiple lines of evidence for disruption of nuclear lamina and nucleoporins in FUS amyotrophic lateral sclerosis.

Multiple lines of evidence for disruption of nuclear lamina and nucleoporins in FUS amyotrophic lateral sclerosis.

Journal: Brain : a journal of neurology

Published: June 27, 2023

Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery.

Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery.

Journal: Cell stem cell

Published: July 03, 2022

Influence of a clinical trial in the decision-making processes of patients with amyotrophic lateral sclerosis.

Influence of a clinical trial in the decision-making processes of patients with amyotrophic lateral sclerosis.

Journal: Journal of neurology

Published: May 22, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026